Number |
Title |
Publication
|
02-33 |
A Phase II Randomized Trial For Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery And BID Irradiation Plus Either Paclitaxel And Cisplatin Or 5-Fluorouracil And Cisplatin Followed By Selective Bladder Preservation And Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy |
|
99-06 |
A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery Plus Taxol, Cisplatin, And BID Irradiation Followed By Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy |
PMID 19100600
|
97-06 |
A Phase I/II Trial In Operable Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery And Cisplatinum/ BID Irradiation Followed by Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy |
PMID 14529770
|
95-06 |
A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed By Either Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder Cancer |
PMID 11110598
|
91-16 |
Pilot Study of the Quality of Life of Bladder Cancer Patients Being Treated on the Companion Protocol RTOG-8903 |
|
89-03 |
A Phase III Trial To Study The Role of Neoadjuvant MCV Chemotherapy Combined With Transurethral Surgery Plus Cisplatin With Radiation Therapy For Selective Bladder Preservation In Patients With Muscle-Invading Bladder Cancer |
PMID 9817278
|
88-14 |
Phase I/II Study of Neoadjuvant Chemotherapy with MCV (MTX/CDDP/VBL) with Intraoperative Electron Beam Radiotherapy and Pre- and Postoperative External Beam Radiotherapy in Patients with Invasive Bladder Carcinoma |
|
88-02 |
Phase I/II Study of Neoadjuvant Combined Modality Treatment with Chemotherapy with MCV (MTX/DDP/VBL) plus Radiotherapy and DDP with Selective Bladder Preservation in Patients with Invasive Bladder Cancer |
PMID 8558186
|
87-05 |
Phase I/II Study of Radiotherapy and Hyperthermia in Patients with Selected Measurable Superficial Tumors |
PMID 8256760
|
87-03 |
Phase I/II Study of Combined Modality Therapy with DDP and Regional Hyperthermia in Patients with Malignancies of the Pelvis and Lower Abdomen |
|
86-08 |
Phase II Trial of WR-2721 Administered Before Protracted Fractionated Radiotherapy in Patients with Cancer of the Rectum, Cervix, or Bladder |
|
85-12 |
Phase II Study of Radiotherapy plus Chemotherapy with cis-Platinum for Stage B/C/D1 Carcinoma of the Bladder with Surgery for Treatment Failures |
PMID 8478228
|
83-08 |
Phase I/II Evaluation of Twice-Daily Fractional Radiotherapy for Locally Advanced Stage B/C/D Transitional Cell and Unresectable Squamous Cell Carcinoma of the Bladder |
PMID 3058657
|
81-10 |
Phase III Photon vs Mixed Beam Preoperative Radiotherapy for Stage B/C/D Carcinoma of the Bladder |
|
81-06 |
Phase III Randomized Comparison of Sandwich vs Standard Preoperative Adjuvant Radiotherapy in Stage B/C Bladder Cancer |
|
81-05 |
Phase I/II Misonidazole and Radiotherapy for Inoperable Bladder Cancer |
|
78-26 |
Photon Radiotherapy vs Pion Radiotherapy for Transitional Cell Carcinoma of the Urinary Bladder |
|
78-21 |
Phase I/II Radiosensitization with Misonidazole plus Radiotherapy for Bladder Cancer |
PMID 7180834
|
78-17 |
Phase II Study of Misonidazole plus Intraoperative Radiotherapy for Nonresectable Carcinomas |
|
78-16 |
Phase I-II Hyperthermia (43.5 Degrees Centigrade) Before and After Radiation Treatment for Human Tumors |
|
78-04 |
Adjuvant Radiotherapy before and after Surgery for Bladder Cancer |
PMID 3967204
|
77-05 |
Radiotherapy with Neutrons Alone or with Photons with or without Surgery for Urinary Bladder Cancer |
PMID 6375854
|
76-12 |
Preoperative or Postoperative Radiotherapy or Radiotherapy Alone for Clinical Stage B1 or B2 or C Bladder Carcinoma |
|
71-04 |
Comparison of Split-Course versus Continuous Radiotherapy for Carcinoma of the Head and Neck and Urogenital Regions |
PMID 4050737
|